Registered by the China Securities Regulatory Commission!, Alumin Alumin | Information | China Securities Regulatory Commission

There are also listed companies and actual controllers under investigation!

On the evening of August 7th, Renfu Pharmaceutical announced that the actual controller of the company, Ai Luming, was filed by the China Securities Regulatory Commission on suspicion of illegal and irregular information disclosure. At the same time, Sante Cableway also announced that the company and its former controlling shareholder, Aluming, have been registered.

Due to suspected violations of laws and regulations in the field of espionage

The Three Special Cableways and the original controller have been filed

On the evening of August 7th, Sante Cableway announced that the company and its former actual controller, Ai Luming, received the "Notice of Filing" issued by the China Securities Regulatory Commission on August 7th, 2023. Due to suspected illegal and irregular information disclosure, the China Securities Regulatory Commission has decided to file a case against the company and Alumin.

San Te Suo Dao stated that the company and Ailuming will actively cooperate with the China Securities Regulatory Commission's investigation work, and strictly comply with relevant laws and regulations and regulatory requirements to timely fulfill information disclosure obligations. At present, the company's various production and business activities are carried out in a normal and orderly manner.

As of the end of the first quarter, Sante Cableway had 22000 shareholders.

The actual controller of Renfu Pharmaceutical has been filed

In addition, Renfu Pharmaceutical also announced that the company has recently received a notice from its actual controller, Aluming. Aluming received a notice from the China Securities Regulatory Commission on August 7, 2023, stating that due to suspected illegal and irregular information disclosure, in accordance with laws and regulations such as the Securities Law of the People's Republic of China and the Administrative Penalty Law of the People's Republic of China, the China Securities Regulatory Commission has decided to file a case against him.

Renfu Pharmaceutical stated that Mr. Ai Luming will actively cooperate with the investigation work of the China Securities Regulatory Commission and strictly fulfill his information disclosure obligations in accordance with regulatory requirements. The directors, supervisors, and senior management of the company are currently performing their duties normally, and the above matters will not have a significant impact on the daily operations of the company. The company will strictly comply with the requirements of regulatory authorities and fulfill its obligation to disclose information on subsequent progress in a timely manner.

As of the end of the first quarter, Renfu Pharmaceutical had 43000 shareholders.

Previously disciplined by the Shanghai Stock Exchange

It is worth noting that in February this year, Renfu Pharmaceutical, its controlling shareholder Wuhan Contemporary Technology Industry Group Co., Ltd., its actual controller Ai Luming, and relevant responsible persons were disciplined by the Shanghai Stock Exchange.

After investigation, it has been found that Renfu Pharmaceutical and its controlling shareholder Contemporary Technology, as well as its actual controller Aluming, have engaged in multiple violations in terms of information disclosure, standardized operation, and the performance of their duties by the responsible persons.

The controlling shareholder of the company has been illegally occupying company funds for a long time without any transaction substance, with a cumulative amount of 12.9 billion yuan, which is huge and serious, reflecting the chaotic financial management and significant deficiencies in internal control of the company, seriously infringing on the interests of the company and small and medium-sized investors.

In addition, it also involves significant violations by controlling shareholders in reducing their holdings, the company's failure to comply with review procedures and information disclosure obligations for major transactions, and inaccurate disclosure of financial data in regular reports.

The Shanghai Stock Exchange pointed out that the controlling shareholder of the company, Contemporary Technology, and the actual controller, Ai Luming, have violated the principle of good faith and have illegally occupied a large amount of funds of the company for a long time, using their controlling position to encroach on the company's interests. The nature of the violation is malicious and the circumstances are serious, and they bear the main responsibility for the illegal behavior of fund occupation.

In view of the above-mentioned violations and circumstances, the Shanghai Stock Exchange has publicly condemned Renfu Pharmaceutical, its controlling shareholder Contemporary Technology, and its actual controller Ai Luming, then Chairman Wang Xuehai, then Director and President Deng Xiafei, and then Vice President and Chief Financial Officer Wu Yajun. It has also publicly determined that Ai Luming is not suitable to serve as a director, supervisor, or senior management of a listed company for three years. At the same time, multiple relevant responsible persons were notified and criticized.

Ai Luming was criticized by the Shenzhen Stock Exchange

In addition, in July of this year, Ai Luming, the actual controller of Sante Cableway, was criticized by the Shenzhen Stock Exchange.

After investigation, it was found that in May 2020, Sante Cableway transferred 100% of its equity in Junshuihe Company and Chongyang Tourism to its wholly-owned subsidiary, Wuhan Contemporary Real Estate Development Co., Ltd. At the same time, in order to avoid industry competition, the tourism assets of Junshuihe Company will be transferred to its wholly-owned subsidiary Chongyang Sante Cultural and Tourism Development Co., Ltd. However, as this portion of tourism assets provided collateral for Chongyang Tourism's 180 million yuan loan in 2016, the existing guarantee constitutes a related guarantee. The company failed to timely fulfill its review procedures and information disclosure obligations for related guarantees.

The actual controller of the company, Ai Luming, has violated relevant regulations and is responsible for the above-mentioned violations. After deliberation and approval by the Disciplinary Committee of the Shenzhen Stock Exchange, it has been decided to impose a disciplinary action of public criticism on the actual controller of the company, Ai Luming, which will be recorded in the integrity file of the listed company and made public to the public.

Hubei Hidden Rich Man

Public information shows that Ai Luming was born in 1957 and once built a huge commercial map. The "Contemporary Group" under his control is a famous private capital group in Hubei, covering multiple fields such as medicine, tourism, and finance.

On October 10, 2019, the "2019 Hurun Rich List" was released, and Ai Luming ranked 666th with a wealth of 6.3 billion yuan, and was once known as the hidden billionaire of Hubei by the outside world. In July 2020, it was selected for Forbes 2020 China Charity List and ranked 15th, with a total cash donation of over 220 million yuan.

In the past 10 years, the listed companies controlled by Ailuming include Renfu Pharmaceutical, Sante Cableway, and * ST Mingcheng. But as the "contemporary series" fell into a debt quagmire, former sports industry star companies * ST Mingcheng and Sante Cableway successively changed ownership.

In February this year, the controlling shareholder of Sante Cableway, Contemporary Urban Construction Development, plans to transfer its 14.98% stake in the company to High Tech Group through an agreement transfer. High tech Group has become the controlling shareholder of the company, and the Wuhan Donghu New Technology Development Zone Management Committee has become the actual controller of the company.

San Te Cableway stated that the purpose of this transaction is to introduce controlling shareholders with state-owned assets and industrial background to the company, fully leverage the resource complementarity and industrial synergy between the two parties, and further enhance San Te Cableway's competitive advantage and comprehensive strength.